The global companion animal health market size was valued at USD 27.4 Billion in 2024, and it is expected to reach USD 55.5 Billion by 2033, exhibiting a growth rate (CAGR) of 7.32% from 2025 to 2033.
To get more information on this market, Request Sample
The companion animal health market is witnessing substantial growth, fueled by continuous innovations and strategic collaborations. A significant driver is the industry’s focus on addressing specific health challenges in pets, such as chronic diseases and conditions requiring specialized treatment. For instance, in January 2024, Boehringer Ingelheim’s SENVELGO (velagliflozin oral solution) was awarded the 2023 Animal Health Best New Product for companion animals. SENVELGO simplifies care and enhances quality of life for both cats and their owners, and it is recognized for its effectiveness in feline diabetes treatment. Also, this development highlights the trend of innovation aimed at fulfilling unmet needs in animal health, resulting in better health outcomes and fostering trust among pet owners and veterinarians. Besides this, mergers and strategic acquisitions are pivotal in driving the market forward by expanding product offerings and technological capabilities. In November 2024, Dechra announced its upcoming acquisition of Invetx, known for developing monoclonal antibodies (mAbs) targeting chronic conditions in pets. This move bolsters Dechra’s portfolio with cutting-edge, long-lasting therapeutic solutions and marks its entry into the rapidly growing market, thereby emphasizing the trend towards advanced biologics in companion animal health. Therefore, such acquisitions enable companies to diversify their products, enhance their market presence, and drive future growth in specialized care for pets.
Moreover, region-specific partnerships are also shaping the landscape by improving accessibility to high-quality veterinary products. In August 2024, Boehringer Ingelheim India formed a strategic distribution partnership with Vvaan Lifesciences Pvt Ltd to expand its pet parasiticide portfolio. This collaboration, under Boehringer Ingelheim’s Animal Health Accelerated Growth Plan (AGP), aims to increase pet healthcare access in Tier 2 cities across India, addressing the growing demand and improving veterinary care standards. Such targeted efforts are crucial in making advanced pet health solutions more widely available, enhancing overall animal well-being in underserved regions. These developments collectively underscore the industry's commitment to innovation, strategic expansion, and improved access to care, reinforcing the positive trajectory of the companion animal health market.
The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America dominates the companion animal health market due to its advanced veterinary infrastructure, high pet ownership rates, and a strong focus on innovative healthcare solutions.
North America is the dominating region in the market due to significant investment in R&D activities and collaborations among industry leaders contribute to the rapid development and distribution of cutting-edge products. In January 2024, BIO-CAT, Inc. partnered with Caldic North America to introduce proprietary probiotic strains and OPTIFEED solutions to the market. This partnership utilizes Caldic's extensive distribution network, enhancing the reach of BIO-CAT’s innovative pet digestive health products. Overall, these collaborations highlight the region's commitment to delivering advanced, high-quality care and supporting the health and well-being of pets, thereby solidifying North America's leadership in the companion animal health sector.
In Europe, the companion animal health market focuses on preventative care and innovative treatments. Germany, for instance, has invested heavily in advanced veterinary technologies and pet wellness services. Also, growth is driven by an increasing number of households with pets and higher spending on animal health. Meanwhile, companies are expanding offerings to include specialized treatments, such as advanced diagnostic tools and therapeutic solutions, thereby boosting overall pet health management.
The Asia Pacific region is experiencing rapid growth in companion animal health, driven by rising pet ownership and a growing middle class. In Japan, advanced veterinary care, including pet insurance and high-quality food, is becoming the norm. The market sees a surge in demand for specialized products, such as nutritional supplements and preventative medications, supported by the increasing awareness of animal well-being.
In Latin America, the companion animal health market is expanding due to increased awareness and spending on pet care. Brazil leads with a robust pet industry and growing veterinary services. The market emphasizes affordable healthcare and vaccination programs. Companies are innovating with cost-effective solutions, such as localized vaccines and nutritional products, to meet the specific needs of the region's pet owners.
The Middle East and Africa are gradually developing their companion animal health markets, with a focus on enhancing veterinary services and pet care awareness. In South Africa, rising disposable income and pet ownership fuel growth in health and wellness products. Besides this, regional trends include increased use of imported high-quality pet food and expanding veterinary clinics offering advanced services despite infrastructure challenges in certain areas.
Some of the leading companion animal health market companies include Agrolabo S.p.A., Boehringer Ingelheim, Ceva Santé Animale, Dechra Pharmaceuticals PLC, Elanco Animal Health Incorporated, IDEXX Laboratories Inc., Indian Immunologicals Limited (National Dairy Development Board), Merck & Co. Inc., Norbrook Laboratories, Vetoquinol SA, Virbac, and Zoetis Inc., among many others. In September 2023, Ceva Santé Animale (Ceva), the global animal health company, announced the launch of its highly anticipated "Call for Projects." This worldwide event aimed to discover and support new, innovative solutions for the well-being and care of companion animals and their pet parents. Moreover, in October 2023, Zoetis announced the U.S. commercial launch of Librela (bedinvetmab injection), demonstrating the company’s advanced leadership in canine innovation and dedication to providing individualized care to address the health needs of dogs.
Report Features | Details |
---|---|
Market Size in 2024 | USD 27.4 Billion |
Market Forecast in 2033 | USD 55.5 Billion |
Market Growth Rate 2025-2033 | 7.32% |
Units | Billion USD |
Scope of the Report | Exploration of Historical Trends and Market Outlook, Industry Catalysts and Challenges, Segment-Wise Historical and Future Market Assessment:
|
Animal Types Covered | Dogs, Cats, Equine, Others |
Products Covered | Vaccines, Pharmaceuticals, Feed Additives, Diagnostics, Others |
End Users Covered | Point-of-care Testing/In-house Testing, Veterinary Hospitals and Clinics, Others |
Regions Covered | Asia Pacific, Europe, North America, Latin America, Middle East and Africa |
Countries Covered | United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico |
Companies Covered | Agrolabo S.p.A., Boehringer Ingelheim, Ceva Santé Animale, Dechra Pharmaceuticals PLC, Elanco Animal Health Incorporated, IDEXX Laboratories Inc., Indian Immunologicals Limited (National Dairy Development Board), Merck & Co. Inc., Norbrook Laboratories, Vetoquinol SA, Virbac, Zoetis Inc., etc. |
Customization Scope | 10% Free Customization |
Post-Sale Analyst Support | 10-12 Weeks |
Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |